Nasdaq

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

“For my patients with moderate to advanced Age-related Macular Degeneration (AMD), a leading cause of vision loss in Americans ages 50 and older, I typically recommend a plan that includes a healthy ...
Nasdaq

Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States

Only Eye Vitamin That Supports Two Health Benefits in One, Clinically Proven AREDS 2 Formula for Eye Health and 100 mg of CoQ10 Antioxidant for Heart Health* VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch ...
Morningstar

Bausch + Lomb Announces Published Review Examining the Role of B Vitamins in Reducing Risk and Progression of Age-Related Macular Degeneration

Drawing on more than two decades of scientific evidence, a comprehensive review synthesizes more than 20 human studies highlighting the potential role of certain B vitamins in supporting eye health to ...
Drug Store News

Bausch + Lomb debuts PreserVision AREDS 2 Formula soft gels plus CoQ10

Bausch + Lomb debuts PreserVision AREDS 2 Formula soft gels plus CoQ10 The soft gels contain the nutrient formula recommended by the National Eye Institute to help reduce the risk of moderate to ...